Nikunj Jain's most recent trade in Sangamo Therapeutics Inc was a trade of 5,119 Common Stock done at an average price of $0.5 . Disclosure was reported to the exchange on Feb. 24, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sangamo Therapeutics Inc | Nikunj Jain | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.47 per share. | 24 Feb 2026 | 5,119 | 237,211 (0%) | 0% | 0.5 | 2,406 | Common Stock |
| Sangamo Therapeutics Inc | Nikunj Jain | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.47 per share. | 24 Feb 2026 | 666 | 242,330 (0%) | 0% | 0.5 | 315 | Common Stock |
| Sangamo Therapeutics Inc | Nikunj Jain | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.40 per share. | 22 Jan 2026 | 7,721 | 242,996 (0%) | 0% | 0.4 | 3,077 | Common Stock |
| Sangamo Therapeutics Inc | Nikunj Jain | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.42 per share. | 24 Nov 2025 | 578 | 245,717 (0%) | 0% | 0.4 | 241 | Common Stock |
| Sangamo Therapeutics Inc | Nikunj Jain | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.66 per share. | 22 Oct 2025 | 6,708 | 246,295 (0%) | 0% | 0.7 | 4,427 | Common Stock |